Company page
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. is a public biotechnology company based in Canada, trading under the ticker MDNA. The company focuses on developing innovative therapies for cancer treatment. As of now, Medicenna has a market capitalization of approximately CAD 20.9 million.
- Ticker
- MDNA:TSX
- Asset type
- Stock
- Market cap
- $20.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD